School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor Darul Ehsan, Malaysia.
Vaccine. 2010 Jul 12;28(31):5005-11. doi: 10.1016/j.vaccine.2010.05.022. Epub 2010 May 21.
Burkholderia pseudomallei is resistant to a wide range of antibiotics, leading to relapse and recrudescence of melioidosis after cessation of antibiotic therapy. More effective immunotherapies are needed for better management of melioidosis. We evaluated the prophylactic potential of the immunogenic outer membrane protein Omp85 as a vaccine against murine melioidosis. Immunization of BALB/c mice with recombinant Omp85 (rOmp85) triggered a Th2-type immune response. Up to 70% of the immunized animals were protected against infectious challenge of B. pseudomallei with reduced bacterial load in extrapulmonary organs. Mouse anti-rOmp85 promoted complement-mediated killing and opsonophagocytosis of B. pseudomallei by human polymorphonuclear cells. In conclusion, we demonstrated that B. pseudomallei Omp85 is potentially able to induce protective immunity against melioidosis.
类鼻疽伯克霍尔德菌对多种抗生素具有耐药性,导致抗生素治疗停止后类鼻疽病的复发和再燃。需要更有效的免疫疗法来更好地管理类鼻疽病。我们评估了免疫原性外膜蛋白 Omp85 作为预防类鼻疽疫苗的潜力。用重组 Omp85(rOmp85)免疫 BALB/c 小鼠引发了 Th2 型免疫反应。高达 70%的免疫动物受到保护,免受类鼻疽伯克霍尔德菌的感染性挑战,肺外器官中的细菌载量减少。小鼠抗 rOmp85 促进了人多形核细胞对类鼻疽伯克霍尔德菌的补体介导的杀伤和调理吞噬作用。总之,我们证明了类鼻疽伯克霍尔德菌 Omp85 有可能诱导对类鼻疽病的保护性免疫。